NEW YORK, March 3, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) resulting from allegations that LogicBio may have issued materially misleading business information to the investing public.
On February 10, 2020, post-market, LogicBio issued a press release announcing "the U.S. Food and Drug Administration (FDA) has placed a clinical hold on [LogicBio's] Investigational New Drug (IND) submission for LB-001 for the treatment of methylmalonic acidemia (MMA) pending the resolution of certain clinical and nonclinical questions."
On this news, shares of LogicBio fell $3.34 per share, or almost 32%, to close at $7.11 per share on February 11, 2020, on unusually high trading volume, damaging investors.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by LogicBio investors. If you purchased shares of LogicBio please visit the firm's website at http://www.rosenlegal.com/cases-register-1776.html to join the class action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-a-globally-recognized-firm-continues-to-investigate-securities-claims-against-logicbio-therapeutics-inc--logc-301015898.html
SOURCE Rosen Law Firm, P.A.